Sapience Investments LLC raised its position in shares of Envision Healthcare Co. (NYSE:EVHC) by 152.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,127,610 shares of the company’s stock after buying an additional 680,220 shares during the quarter. Envision Healthcare comprises 5.3% of Sapience Investments LLC’s portfolio, making the stock its largest position. Sapience Investments LLC owned approximately 0.93% of Envision Healthcare worth $38,970,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. CI Investments Inc. bought a new position in shares of Envision Healthcare during the third quarter valued at approximately $9,084,000. Wells Fargo & Company MN grew its holdings in shares of Envision Healthcare by 11.2% during the third quarter. Wells Fargo & Company MN now owns 917,418 shares of the company’s stock valued at $41,238,000 after purchasing an additional 92,339 shares during the last quarter. OZ Management LP bought a new position in shares of Envision Healthcare during the third quarter valued at approximately $131,987,000. Hexavest Inc. grew its holdings in shares of Envision Healthcare by 1.1% during the fourth quarter. Hexavest Inc. now owns 655,516 shares of the company’s stock valued at $22,655,000 after purchasing an additional 7,270 shares during the last quarter. Finally, Quantitative Systematic Strategies LLC grew its holdings in shares of Envision Healthcare by 17.9% during the fourth quarter. Quantitative Systematic Strategies LLC now owns 14,319 shares of the company’s stock valued at $495,000 after purchasing an additional 2,169 shares during the last quarter.
Envision Healthcare Co. (EVHC) opened at $42.89 on Monday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 3.38 and a current ratio of 3.40. The stock has a market capitalization of $5,186.47, a price-to-earnings ratio of -20.72, a price-to-earnings-growth ratio of 1.07 and a beta of 0.48. Envision Healthcare Co. has a one year low of $23.77 and a one year high of $67.45.
Several research firms have recently commented on EVHC. Robert W. Baird reaffirmed an “outperform” rating and set a $50.00 target price (up from $45.00) on shares of Envision Healthcare in a report on Wednesday, March 7th. Mizuho set a $38.00 target price on Envision Healthcare and gave the company a “hold” rating in a report on Friday, March 2nd. Royal Bank of Canada reaffirmed a “buy” rating and set a $48.00 target price on shares of Envision Healthcare in a report on Thursday, March 1st. SunTrust Banks upped their target price on Envision Healthcare to $45.00 and gave the company a “buy” rating in a report on Thursday, March 1st. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $46.00 target price (up from $32.00) on shares of Envision Healthcare in a report on Wednesday, February 28th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and nine have assigned a buy rating to the company. Envision Healthcare presently has an average rating of “Hold” and an average price target of $42.57.
TRADEMARK VIOLATION NOTICE: “Envision Healthcare Co. (EVHC) Holdings Increased by Sapience Investments LLC” was posted by American Banking News and is the property of of American Banking News. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2018/03/12/envision-healthcare-co-evhc-holdings-increased-by-sapience-investments-llc.html.
Envision Healthcare Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.